Citations (156)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
A. Abravan, A. Salem, G. Price, C. Faivre-Finn & M. van Herk. (2022) Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study. Acta Oncologica 61:2, pages 163-171.
Read now
Read now
Di Wang, Xia Zhang, Yajie Gao, Xiaonan Cui, Yanqin Yang, Weifeng Mao, Minghuan Li, Bin Zhang & Jinming Yu. (2020) Research Progress and Existing Problems for Abscopal Effect. Cancer Management and Research 12, pages 6695-6706.
Read now
Read now
Anna F. Piotrowski, Thomas R. Nirschl, Esteban Velarde, Lee Blosser, Sudipto Ganguly, Kathleen H. Burns, Leo Luznik, John Wong, Charles G. Drake & Stuart A. Grossman. (2018) Systemic depletion of lymphocytes following focal radiation to the brain in a murine model. OncoImmunology 7:7.
Read now
Read now
Jian L. Campian, Xiaobu Ye, Guneet Sarai, Joseph Herman & Stuart A. Grossman. (2018) Severe Treatment-Related Lymphopenia in Patients with Newly Diagnosed Rectal Cancer. Cancer Investigation 36:6, pages 356-361.
Read now
Read now
Lawrence Kleinberg. (2016) Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy. Patient Preference and Adherence 10, pages 2397-2406.
Read now
Read now
Mehrdad Talebian Yazdi, Mink S. Schinkelshoek, Nikki M. Loof, Christian Taube, Pieter S. Hiemstra, Marij J. P. Welters & Sjoerd H. van der Burg. (2016) Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer. OncoImmunology 5:12.
Read now
Read now
Susannah Ellsworth, Ani Balmanoukian, Ferdynand Kos, Christopher J Nirschl, Thomas R Nirschl, Stuart A Grossman, Leo Luznik & Charles G Drake. (2014) Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide. OncoImmunology 3:1.
Read now
Read now
Articles from other publishers (149)
Cole Friedes, Michelle Iocolano, Sang Ho Lee, Lian Duan, Bolin Li, Abigail Doucette, Roger B. Cohen, Charu Aggarwal, Lova L. Sun, William P. Levin, Keith A. Cengel, Gary Kao, Boon-Keng Kevin Teo, Corey J. Langer, Ying Xiao, Jeffrey Bradley, Steven J. Feigenberg & Nikhil Yegya-Raman. (2024) The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC. Radiotherapy and Oncology 190, pages 110030.
Crossref
Crossref
Peter S. N. van Rossum, Celia Juan-Cruz, Barbara Stam, Maddalena M. G. Rossi, Steven H. Lin, Azadeh Abravan, José S. A. Belderbos & Jan-Jakob Sonke. (2023) Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models. Frontiers in Oncology 13.
Crossref
Crossref
Li He, Chenhan Zhong, Hang Chang, Jamie L. Inman, Susan E. Celniker, Myrsini Ioakeim-Ioannidou, Kevin X. Liu, Daphne Haas-Kogan, Shannon M. MacDonald, David W. Threadgill, Scott C. Kogan, Jian-Hua Mao & Antoine M. Snijders. (2023) Genetic architecture of the acute and persistent immune cell response after radiation exposure. Cell Genomics 3:11, pages 100422.
Crossref
Crossref
Jinliang Zhang, Li Yang, Hui Li, Jeff W. Chan, Eric K.W. Lee, Min Liu, Lingyu Ma, Qin Liu, Jian-Yue Jin, Pingfu Fu, Zhiyuan Xu & Feng-Ming (Spring) Kong. (2023) Dosimetric Effect of Thymus and Thoracic Duct on Radiation-Induced Lymphopenia in Patients With Primary Lung Cancer Who Received Thoracic Radiation. Advances in Radiation Oncology 8:6, pages 101260.
Crossref
Crossref
Rui Zhou, Bo Qiu, Mai Xiong, YiMei Liu, KangQiang Peng, YiFeng Luo, DaQuan Wang, FangJie Liu, NaiBin Chen, JinYu Guo, Jun Zhang, XiaoYan Huang, YuMing Rong & Hui Liu. (2023) Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049). International Journal of Radiation Oncology*Biology*Physics 117:2, pages 387-399.
Crossref
Crossref
Chang Ik Yoon, Jawon Hwang, Dooreh Kim, Jung Hwan Ji, Janghee Lee, Soong June Bae, Joon Jeong, Jee-Suk Chang, Yeona Cho, Hye Sun Lee, Jee Ye Kim & Sung Gwe Ahn. (2023) Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery. Scientific Reports 13:1.
Crossref
Crossref
Alvaro Marcos Rubio, Celine Everaert, Eufra Van Damme, Katleen De Preter & Karim Vermaelen. (2023) Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer 11:8, pages e007023.
Crossref
Crossref
Yaqi Li, Xingwen Fan, Qi Yu, Haoyang Zhai, Miao Mo, Jiayao Sun, Jing Mi, Renquan Lu, Jingfang Mao, Jian Chen, Ningyi Ma, Wenxuan Yang, Ji Zhu, Guoliang Jiang & Kailiang Wu. (2023) Proton and Carbon Ion Radiation Therapy Decreased Severe Lymphopenia by Reducing Thoracic Vertebra and Aortic Doses in Non-Small Cell Lung Cancer Versus Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 116:3, pages 579-589.
Crossref
Crossref
Corentin Pasquier, Léonor Chaltiel, Carole Massabeau, Audrey Rabeau, Louisiane Lebas, Amélie Lusque, Jean-Sébastien Texier, Elizabeth Cohen-Jonathan Moyal, Julien Mazières & Jonathan Khalifa. (2023) Impact of radiation on host immune system in patients treated with chemoradiotherapy and durvalumab consolidation for unresectable locally advanced non-small cell lung cancer. Frontiers in Oncology 13.
Crossref
Crossref
Shuang Li, Weiping Yao, Ruiqi Liu, Yanwei Lu, Haibo Zhang & Xiaodong Liang. (2023) Severe lymphopenia as a prognostic factor in rectal cancer patients receiving adjuvant chemoradiotherapy: a retrospective study. Scientific Reports 13:1.
Crossref
Crossref
Yu‐Jung Lin, Yu‐Mei Kang, Yuan‐Hung Wu, Yi‐Wei Chen & Yu‐Wen Hu. (2023) Lymphocytopenia and survival after whole‐brain radiotherapy in patients with small‐cell lung cancer. Thoracic Cancer 14:14, pages 1268-1275.
Crossref
Crossref
Yejin Kim, Ibrahim Chamseddine, Yeona Cho, Jin Sung Kim, Radhe Mohan, Nadya Shusharina, Harald Paganetti, Steven Lin, Hong In Yoon, Seungryong Cho & Clemens Grassberger. (2023) Neural network based ensemble model to predict radiation induced lymphopenia after concurrent chemo-radiotherapy for non-small cell lung cancer from two institutions. Neoplasia 39, pages 100889.
Crossref
Crossref
Heng Chen, Zhonglong Liu, Kun Yue, Jiping Ding & Yue He. (2023) Immune microenvironment: novel perspectives on bone regeneration disorder in osteoradionecrosis of the jaws. Cell and Tissue Research 392:2, pages 413-430.
Crossref
Crossref
Mathieu Césaire, Audrey Rambeau, Florian Clatot, Alisson Johnson, Natacha Heutte & Juliette Thariat. (2022) Impact of lymphopenia on efficacy of nivolumab in head and neck cancer patients. European Archives of Oto-Rhino-Laryngology 280:5, pages 2453-2461.
Crossref
Crossref
Janhavi Athale, Kristen Broderick, Xiaojun Wu & Stuart Grossman. (2023) Evidence for Persistent Radiation-Related Injury to the Immune System in Patients With Local Breast Cancer. International Journal of Radiation Oncology*Biology*Physics 115:5, pages 1192-1196.
Crossref
Crossref
M. Césaire, A. Rambeau, F. Cherifi, B. Géry, A. Johnson, M. Nacher & J. Thariat. (2023) Effect of lymphoid volume irradiation on radiation-induced lymphopenia in head and neck cancers. Cancer/Radiothérapie 27:2, pages 145-153.
Crossref
Crossref
Masatoshi Nakamura, Hitoshi Ishikawa, Kayoko Ohnishi, Yutarou Mori, Keiichiro Baba, Kensuke Nakazawa, Toshihiro Shiozawa, Ikuo Sekine, Kazushi Maruo, Toshiyuki Okumura & Hideyuki Sakurai. (2023) Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer. Journal of Radiation Research 64:2, pages 438-447.
Crossref
Crossref
Yasmine El Houat, Christophe Massard, Veronique Quillien, Renaud de Crevoisier & Joël Castelli. (2023) Meta-analysis and Critical Review: Association Between Radio-induced Lymphopenia and Overall Survival in Solid Cancers. Advances in Radiation Oncology 8:2, pages 101038.
Crossref
Crossref
Subhajit Ghosh, Jiayi Huang, Matthew Inkman, Jin Zhang, Sukrutha ThotalaEkaterina Tikhonova, Natalia Miheecheva, Felix Frenkel, Ravshan Ataullakhanov, Xiaowei Wang, David DeNardo, Dennis HallahanDinesh Thotala. (2023) Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma. Science Translational Medicine 15:680.
Crossref
Crossref
Sarah Boughdad, Michael Da Mota, Mélanie Mendes De Carvalho, Maria Firsova, John O. Prior & Niklaus Schaefer. (2022) Lymphopenia during 177Lu-DOTATATE therapy leading to recurrence of tuberculosis: a case report. European Journal of Hybrid Imaging 6:1.
Crossref
Crossref
Sayaka Misaki, Satoshi Murata, Miyuki Shimoji, Takayasu Iwai, Andreas Michael Sihombing, Ken Aoki, Yutaka Takahashi & Yoshiyuki Watanabe. (2022) Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2-positive murine tumor. Japanese Journal of Radiology 40:12, pages 1307-1315.
Crossref
Crossref
FangJie Liu, YingJia Wu, JianHui Shao, Bo Qiu, SuPing Guo, QiaoTing Luo, JinYu Guo, DaQuan Wang, Chu Chu, Rui Zhou, NaiBin Chen, XinLei Ai & Hui Liu. (2022) Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients. Frontiers in Oncology 12.
Crossref
Crossref
Elías Gomis Sellés, Blas David Delgado León, Patricia Cabrera Roldán, Catalina Márquez Vega, Eleonor Rivin del Campo & José Luis López Guerra. (2022) Haematological and renal toxicity of radiation therapy in neuroblastoma paediatric patients. Clinical and Translational Oncology 25:3, pages 786-795.
Crossref
Crossref
Eva Bogaerts, Ellina Macaeva, Sofie Isebaert & Karin Haustermans. (2022) Potential Molecular Mechanisms behind the Ultra-High Dose Rate “FLASH” Effect. International Journal of Molecular Sciences 23:20, pages 12109.
Crossref
Crossref
Supriya Mallick, Anjali V.R, Prashanth Giridhar, Rituraj Upadhyay, Byung-Kyu Kim, Amrish Sharma, Hagar Elghazawy, Thiraviyam Elumalai, Vinod Solipuram, Cheng En Hsieh, Courtney Hentz, Abhishek A. Solanki, Jing Li, Dennis Pai Chan, Emily Ness, Bhanu Prasad Venkatesulu & David R. Grosshans. (2022) A Systematic Review and Meta-analysis of the Impact of Radiation-Related Lymphopenia on Outcomes in High-Grade Gliomas. South Asian Journal of Cancer 11:04, pages 361-369.
Crossref
Crossref
Binwei Lin, Dan Huang, Feng Gao, Yiwei Yang, Dai Wu, Yu Zhang, Gang Feng, Tangzhi Dai & Xiaobo Du. (2022) Mechanisms of FLASH effect. Frontiers in Oncology 12.
Crossref
Crossref
Zhiyuan Xu, Li Yang, Hao Yu & Linlang Guo. (2022) A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer. Frontiers in Oncology 12.
Crossref
Crossref
Wang Jing, Ting Xu, Lirong Wu, Pablo B. Lopez, Clemens Grassberger, Susannah G. Ellsworth, Radhe Mohan, Brian P. Hobbs, George R. Blumenschein, Janet Tu, Mehmet Altan, Percy Lee, Zhongxing Liao & Steven H. Lin. (2022) Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC. JTO Clinical and Research Reports 3:9, pages 100391.
Crossref
Crossref
Melak Aynalem, Nurayni Adem, Firdews Wendesson, Bewket Misganaw, Simegnew Mintesnot, Nega Godo, Solomon Getawa, Tiruneh Adane, Berhanu Woldu & Elias Shiferaw. (2022) Hematological abnormalities before and after initiation of cancer treatment among breast cancer patients attending at the University of Gondar comprehensive specialized hospital cancer treatment center. PLOS ONE 17:8, pages e0271895.
Crossref
Crossref
Chengrun Du, Mengshan Ni, Jianyun Jiang, Fangfang Kong, Ruiping Zhai, Yingchen Lv, Chaosu Hu & Hongmei Ying. (2022) Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis. European Archives of Oto-Rhino-Laryngology 279:8, pages 3947-3956.
Crossref
Crossref
Dongjun Dai, Qiaoying Tian, Genhua Yu, Yongjie Shui, Hao Jiang & Qichun Wei. (2022) Severe Radiation-Induced Lymphopenia Affects the Outcomes of Esophageal Cancer: A Comprehensive Systematic Review and Meta-Analysis. Cancers 14:12, pages 3024.
Crossref
Crossref
Mathieu Césaire, Juliette Montanari, Hubert Curcio, Delphine Lerouge, Radj Gervais, Pierre Demontrond, Jacques Balosso & François Chevalier. (2022) Radioresistance of Non-Small Cell Lung Cancers and Therapeutic Perspectives. Cancers 14:12, pages 2829.
Crossref
Crossref
Sherif G. ShaabanMB ChBMB ChB, Daniel EbnerMD, MPHMD, MPH & Osama MohamadMD, PhDMD, PhD. 2022. Principles and Practice of Particle Therapy. Principles and Practice of Particle Therapy
151
163
.
Roberto Mapelli, Chiara Julita, Sofia Paola Bianchi, Nicolò Gallina, Raffaella Lucchini, Martina Midulla, Flavia Puci, Jessica Saddi, Sara Trivellato, Denis Panizza, Elena De Ponti & Stefano Arcangeli. (2021) Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy. Strahlentherapie und Onkologie 198:5, pages 448-457.
Crossref
Crossref
Saba Ebrahimi, Gino Lim, Brian P. Hobbs, Steven H. Lin, Radhe Mohan & Wenhua Cao. (2022) A hybrid deep learning model for forecasting lymphocyte depletion during radiation therapy. Medical Physics 49:5, pages 3507-3522.
Crossref
Crossref
Li Yang, Zhiyuan Xu, Lingyu Ma, Qin Liu, Amy T.Y. Chang, Qian Wang, Jiandong Zha, Jinliang Zhang, Xiaoqin Jiang, Jingjing Zhang, Feng-Ming (Spring) Kong & Linlang Guo. (2022) Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer. Cancer Biomarkers 34:1, pages 149-159.
Crossref
Crossref
Feiya Shi, Alison K. Yoder, Claire Mach, Shraddha Dalwadi, Matthew L Anderson, Tracilyn R Hall & Michelle S Ludwig. (2022) Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer. Obstetrics & Gynecology Science 65:2, pages 176-187.
Crossref
Crossref
Jian L. Campian, Subhajit Ghosh, Vaishali Kapoor, Ran Yan, Sukrutha Thotala, Arijita Jash, Tong Hu, Anita Mahadevan, Kasem Rifai, Logan Page, Byung Ha Lee, Sara Ferrando-Martinez, Alexandra A. Wolfarth, Se Hwan Yang, Dennis Hallahan, Milan G. Chheda & Dinesh Thotala. (2022) Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models. Clinical Cancer Research 28:6, pages 1229-1239.
Crossref
Crossref
Yeona Cho, Yejin Kim, Ibrahim Chamseddine, Won Hee Lee, Hye Ryun Kim, Ik Jae Lee, Min Hee Hong, Byung Chul Cho, Chang Geol Lee, Seungryong Cho, Jin Sung Kim, Hong In Yoon & Clemens Grassberger. (2022) Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy. Radiotherapy and Oncology 168, pages 1-7.
Crossref
Crossref
Eunji Kim, Tae Hyung Kim, Wonguen Jung, Kyubo Kim, Ah Ram Chang, Hae Jin Park, Hyeon Kang Koh, Semie Hong, Kyung Hwan Kim, Jee Suk Chang, Woong Sub Koom, Won Il Jang & Mi-Sook Kim. (2021) Prognostic impact of neutrophilia and lymphopenia on survival in anal cancer treated with definitive concurrent chemoradiotherapy: a retrospective multicenter study. International Journal of Clinical Oncology 27:3, pages 553-562.
Crossref
Crossref
Shu Xing, Jungwook Shin, Jennifer Pursley, Camilo M Correa-Alfonso, Nicolas Depauw, Sean Domal, Julia Withrow, Wesley Bolch, Clemens Grassberger & Harald Paganetti. (2022) A dynamic blood flow model to compute absorbed dose to circulating blood and lymphocytes in liver external beam radiotherapy. Physics in Medicine & Biology 67:4, pages 045010.
Crossref
Crossref
Annaig Bertho, Lorea Iturri & Yolanda Prezado. 2022.
Zsuzsa S. Kocsis, Tibor Major, Csilla Pesznyák, Dalma Mihály, Gábor Stelczer, Márta Kun-Gazda, Gyöngyi Farkas, Gábor Székely, Péter Ágoston, Kliton Jorgo, László Gesztesi, Csaba Polgár & Zsolt Jurányi. (2021) Relationship between biodosimetric parameters and treatment volumes in three types of prostate radiotherapy. Scientific Reports 11:1.
Crossref
Crossref
Jian-Yue Jin, Chen Hu, Ying Xiao, Hong Zhang, Rebecca Paulus, Susannah G. Ellsworth, Steven E. Schild, Jeffrey A. Bogart, Michael Chris Dobelbower, Vivek S. Kavadi, Samir Narayan, Puneeth Iyengar, Cliff Robinson, Joel S. Greenberger, Christopher Koprowski, Mitchell Machtay, Walter Curran, Hak Choy, Jeffrey D. Bradley & Feng-Ming (Spring) Kong. (2021) Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617. Cancers 13:24, pages 6193.
Crossref
Crossref
Abhinav V. Reddy, Matthew P. Deek, Juan F. Jackson, Colin S. Hill, Shuchi Sehgal, Jin He, Lei Zheng, Joseph M. Herman, Jeffrey Meyer & Amol K. Narang. (2021) Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy. Radiation Oncology 16:1.
Crossref
Crossref
Jing Xi, Bilal Hassan, Ruth G. N. Katumba, Karam Khaddour, Akshay Govindan, Jingqin Luo, Jiayi Huang & Jian L. Campian. (2021) The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma. BMC Cancer 21:1.
Crossref
Crossref
Pim J.J. Damen, Tiuri E. Kroese, Richard van Hillegersberg, Ewoud Schuit, Max Peters, Joost J.C. Verhoeff, Steven H. Lin & Peter S.N. van Rossum. (2021) The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis. International Journal of Radiation Oncology*Biology*Physics 111:4, pages 936-948.
Crossref
Crossref
Saba Ebrahimi, Gino Lim, Amy Liu, Steven H. Lin, Susannah G. Ellsworth, Clemens Grassberger, Radhe Mohan & Wenhua Cao. (2021) Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients. International Journal of Particle Therapy 8:2, pages 17-27.
Crossref
Crossref
Cong Zhu, Radhe Mohan, Steven H. Lin, Goo Jun, Ashraf Yaseen, Xiaoqian Jiang, Qianxia Wang, Wenhua Cao & Brian P. Hobbs. (2021) Identifying Individualized Risk Profiles for Radiotherapy-Induced Lymphopenia Among Patients With Esophageal Cancer Using Machine Learning. JCO Clinical Cancer Informatics:5, pages 1044-1053.
Crossref
Crossref
Qian Zhao, Butuo Li, Yiyue Xu, Shijiang Wang, Bing Zou, Jinming Yu & Linlin Wang. (2021) Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non‐small cell lung cancer. Cancer Medicine 10:18, pages 6291-6303.
Crossref
Crossref
O. Nicholas, S. Prosser, H.R. Mortensen, G. Radhakrishna, M.A. Hawkins & S.H. Gwynne. (2021) The Promise of Proton Beam Therapy for Oesophageal Cancer: A Systematic Review of Dosimetric and Clinical Outcomes. Clinical Oncology 33:8, pages e339-e358.
Crossref
Crossref
A. Punjabi, E. Barrett, A. Cheng, A. Mulla, G. Walls, D. Johnston, J. McAleese, K. Moore, J. Hicks, K. Blyth, M. Denholm, L. Magee, D. Gilligan, S. Silverman, M. Qureshi, H. Clinch, M. Hatton, L. Philipps, S. Brown, M. O'Brien, F. McDonald, C. Faivre-Finn, C. Hiley & M. Evison. (2021) Neutrophil–Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer. Clinical Oncology 33:8, pages e331-e338.
Crossref
Crossref
Caressa Hui, Brittney Chau, Greg Gan, William Stokes, Sana D. Karam & Arya Amini. (2021) Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review. Frontiers in Oncology 11.
Crossref
Crossref
Mauricio E. Gamez & Daniel J. Ma. (2021) Deintensification Strategies Using Proton Beam Therapy for HPV-Related Oropharyngeal Cancer. International Journal of Particle Therapy 8:1, pages 223-233.
Crossref
Crossref
Jinlin Jiang & Sanjeev Ahuja. (2021) Addressing Patient to Patient Variability for Autologous CAR T Therapies. Journal of Pharmaceutical Sciences 110:5, pages 1871-1876.
Crossref
Crossref
Wang Jing, Yufei Liu, Hui Zhu, James Welsh, Saumil Gandhi, Melenda Jeter, Quynh Nguyen, Aileen B. Chen, Michael O'Reilly, Zhongxing Liao, Joe Y. Chang, Percy Lee & Steven H. Lin. (2021) Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study. Clinical and Translational Radiation Oncology 28, pages 54-61.
Crossref
Crossref
Jonathan Khalifa, Julien Mazieres, Carlos Gomez-Roca, Maha Ayyoub & Elizabeth Cohen-Jonathan Moyal. (2021) Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas?. Frontiers in Oncology 11.
Crossref
Crossref
Rituraj Upadhyay, Bhanu Prasad Venkatesulu, Prashanth Giridhar, B.K. Kim, Amrish Sharma, Hagar Elghazawy, Bhaswanth Dhanireddy, Thiraviyam Elumalai, Supriya Mallick & Matthew Harkenrider. (2021) Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis. Radiotherapy and Oncology 157, pages 225-233.
Crossref
Crossref
Cole Friedes, Turja Chakrabarti, Sarah Olson, Laura Prichett, Julie R. Brahmer, Patrick M. Forde, Ranh K. Voong, Kristen A. Marrone, Vincent K. Lam, Christine L. Hann, Stephen R. Broderick, Richard J. Battafarano, Jinny S. Ha, Errol L. Bush, Stephen C Yang, Russel K. Hales & Josephine L. Feliciano. (2021) Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy. Lung Cancer 154, pages 36-43.
Crossref
Crossref
Jia-Lin Wang, Rong Ma, Wei Kong, Ren Zhao & Yan-Yang Wang. (2021) Lymphopenia in Esophageal Cancer: What Have We Learned?. Frontiers in Oncology 11.
Crossref
Crossref
Yao‐Yu Wu, Kai‐Ping Chang, Tsung‐Ying Ho, Wen‐Chi Chou, Sheng‐Ping Hung, Kang‐Hsing Fan, Yin‐Yin Chiang, Yung‐Chih Chou & Ngan‐Ming Tsang. (2021) Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy. Cancer Medicine 10:6, pages 1975-1988.
Crossref
Crossref
Radhe Mohan, Amy Y Liu, Paul D Brown, Anita Mahajan, Jeffrey Dinh, Caroline Chung, Sarah McAvoy, Mary Frances McAleer, Steven H Lin, Jing Li, Amol J Ghia, Cong Zhu, Erik P Sulman, John F de Groot, Amy B Heimberger, Susan L McGovern, Clemens Grassberger, Helen Shih, Susannah Ellsworth & David R Grosshans. (2021) Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons. Neuro-Oncology 23:2, pages 284-294.
Crossref
Crossref
Slavisa Tubin, Mohammad K. Khan, Seema Gupta & Branislav Jeremic. (2021) Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment. Cancers 13:4, pages 775.
Crossref
Crossref
Stanislav Lazarev, Kenneth Rosenzweig, Robert Samstein, Lucas Resende Salgado, Shaakir Hasan, Robert H. Press, Sonam Sharma, Charles A. Powell, Fred R. Hirsch & Charles B. SimoneIIII. (2021) Where are we with proton beam therapy for thoracic malignancies? Current status and future perspectives. Lung Cancer 152, pages 157-164.
Crossref
Crossref
Chia-Hsin Lin, Wen-Chi Chou, Yao-Yu Wu, Chien-Yu Lin, Kai-Ping Chang, Chun-Ta Liao, Tsung-Ying Ho, Chiu-Mei Yeh, Chia-Jen Liu, Sheng-Ping Hung, Ching-Hsin Lee, Po-Jui Chen, Yung-Chih Chou, Kang-Hsing Fan, Bing-Shen Huang, Joseph Tung-Chieh Chang, Chun-Chieh Wang & Ngan-Ming Tsang. (2021) Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study. Radiotherapy and Oncology 154, pages 76-86.
Crossref
Crossref
Grace Lee, Daniel W. Kim, Vinayak Muralidhar, Devarati Mitra, Nora K. Horick, Christine E. Eyler, Theodore S. Hong, Lorraine C. Drapek, Jill N. Allen, Lawrence S. Blaszkowsky, Bruce Giantonio, Aparna R. Parikh, David P. Ryan, Jeffrey W. Clark & Jennifer Y. Wo. (2020) Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal Canal. The Oncologist 25:12, pages 1015-1022.
Crossref
Crossref
Xiaoxue Xie, Shenglan Gong, Hekun Jin, Pei Yang, Ting Xu, Yilong Cai, Chengxian Guo, Rong Zhang, Fan Lou, Wenjuan Yang & Hui Wang. (2020) Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count. Radiation Oncology 15:1.
Crossref
Crossref
Juliana Matiello, Alan Dal Pra, Laise Zardo, Ricardo Silva & Danilo C Berton. (2020)
Impacts of post‐radiotherapy lymphocyte count on progression‐free and overall survival in patients with stage
III
lung cancer
. Thoracic Cancer 11:11, pages 3139-3144.
Crossref
Crossref
Tithi Biswas, Kylie H. Kang, Rohin Gawdi, David Bajor, Mitchell Machtay, Charu Jindal & Jimmy T. Efird. (2020) Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC). International Journal of Environmental Research and Public Health 17:21, pages 7995.
Crossref
Crossref
Azadeh Abravan, Corinne Faivre-Finn, Jason Kennedy, Alan McWilliam & Marcel van Herk. (2020) Radiotherapy-Related Lymphopenia Affects Overall Survival in Patients With Lung Cancer. Journal of Thoracic Oncology 15:10, pages 1624-1635.
Crossref
Crossref
Guang-Yi Sun, Shu-Lian Wang, Yong-Wen Song, Jing Jin, Wei-Hu Wang, Yue-Ping Liu, Hua Ren, Hui Fang, Yu Tang, Xu-Ran Zhao, Yu-Chun Song, Zi-Hao Yu, Xin-Fan Liu & Ye-Xiong Li. (2020) Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients With Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 108:1, pages 277-285.
Crossref
Crossref
Sung Ho Moon & Yang-Gun Suh. (2020) The Role of Modern Radiotherapy Technology in the Treatment of Esophageal Cancer. The Korean Journal of Thoracic and Cardiovascular Surgery 53:4, pages 184-190.
Crossref
Crossref
Jian-Yue Jin, Anxin Gu, Weili Wang, Nancy L. Oleinick, Mitchell Machtay & Feng-Ming (Spring) Kong. (2020) Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?. Radiotherapy and Oncology 149, pages 55-62.
Crossref
Crossref
Edy Ippolito, Michele Fiore, Carlo Greco, Rolando Maria D'Angelillo & Sara Ramella. (2020) COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases. Radiotherapy and Oncology 148, pages 201-202.
Crossref
Crossref
Michele Dal Bo, Elena De Mattia, Lorena Baboci, Silvia Mezzalira, Erika Cecchin, Yehuda G. Assaraf & Giuseppe Toffoli. (2020) New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma. Drug Resistance Updates 51, pages 100702.
Crossref
Crossref
Mathieu Cesaire, Brigitte Le Mauff, Audrey Rambeau, Olivier Toutirais & Juliette Thariat. (2020) Mécanismes de la lymphopénie radio-induite et implications thérapeutiques. Bulletin du Cancer 107:7-8, pages 813-822.
Crossref
Crossref
Vaishali Kapoor, Andrea Collins, Kaylan Griffith, Subhajit Ghosh, Nathan Wong, Xiaowei Wang, Grant A. Challen, Joseph Krambs, Dan Link, Dennis E. Hallahan & Dinesh Thotala. (2020) Radiation induces iatrogenic immunosuppression by indirectly affecting hematopoiesis in bone marrow. Oncotarget 11:19, pages 1681-1690.
Crossref
Crossref
Cai Xu, Jian-Yue Jin, Ming Zhang, Amy Liu, Jun Wang, Radhe Mohan, Fengming (Spring) Kong & Steven H. Lin. (2020) The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy. Radiotherapy and Oncology 146, pages 180-186.
Crossref
Crossref
Azadeh Abravan, Hanne Astrid Eide, Åslaug Helland & Eirik Malinen. (2020) Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy. Clinical and Translational Radiation Oncology 22, pages 15-21.
Crossref
Crossref
Zhenwei Zou, Stephen R. Bowen, Hannah M.T. Thomas, Balu Krishna Sasidharan, Ramesh Rengan & Jing Zeng. (2020) Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes. Advances in Radiation Oncology 5:3, pages 434-443.
Crossref
Crossref
Sweet Ping Ng, Houda Bahig, Amit Jethanandani, Courtney Pollard, Joel Berends, Erich M. Sturgis, Faye M. Johnson, Baher Elgohari, Hesham Elhalawani, David I. Rosenthal, Heath D. Skinner, G. Brandon Gunn, Jack Phan, Steven J. Frank, Abdallah S.R. Mohamed, Clifton D. Fuller & Adam S. Garden. (2020) Lymphopenia during radiotherapy in patients with oropharyngeal cancer. Radiotherapy and Oncology 145, pages 95-100.
Crossref
Crossref
Changhee Kang, Seong-Yun Jeong, Si Yeol Song & Eun Kyung Choi. (2020) The emerging role of myeloid-derived suppressor cells in radiotherapy. Radiation Oncology Journal 38:1, pages 1-10.
Crossref
Crossref
Abdelkhalek Hammi, Harald Paganetti & Clemens Grassberger. (2020) 4D blood flow model for dose calculation to circulating blood and lymphocytes. Physics in Medicine & Biology 65:5, pages 055008.
Crossref
Crossref
Jian-Yue Jin, Todd Mereniuk, Anirudh Yalamanchali, Weili Wang, Mitchell Machtay, Feng-Ming (Spring)Kong & Susannah Ellsworth. (2020) A framework for modeling radiation induced lymphopenia in radiotherapy. Radiotherapy and Oncology 144, pages 105-113.
Crossref
Crossref
Alexander D. Sherry, Neil B. Newman, Joshua L. Anderson & Evan C. Osmundson. (2019) Systemic inflammatory dynamics during chemoradiotherapy predict response, relapse, metastasis, and survival in esophageal carcinoma. Journal of Surgical Oncology 121:2, pages 303-312.
Crossref
Crossref
Qianqian Zhao, Tingting Li, Gang Chen, Zhaochong Zeng & Jian He. (2020) Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy. Frontiers in Oncology 9.
Crossref
Crossref
Xin Wang, Peiliang Wang, Zongxing Zhao, Qingfeng Mao, Jinming Yu & Minghuan Li. (2020) A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy. Therapeutic Advances in Medical Oncology 12, pages 175883592092682.
Crossref
Crossref
Pedro Barata, Jodi Layton, Brian Lewis & Oliver Sartor. (2020) Next Generation of Androgen Deprivation Therapy Combined With Radiotherapy for N0 M0 Prostate Cancer. The Cancer Journal 26:1, pages 21-28.
Crossref
Crossref
Joris B.W. Elbers, Abrahim Al-Mamgani, Margot E.T. Tesseslaar, Michiel W.M. van den Brekel, Charlotte A.H. Lange, Jacqueline E. van der Wal, Marcel Verheij, Charlotte L. Zuur & Jan Paul de Boer. (2020) Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial. Radiotherapy and Oncology 142, pages 79-84.
Crossref
Crossref
Elena Garelli, Achim Rittmeyer, Paul Martin Putora, Markus Glatzer, Ralf Dressel & Stefan Andreas. (2019) Abscopal effect in lung cancer: three case reports and a concise review. Immunotherapy 11:17, pages 1445-1461.
Crossref
Crossref
Slavisa Tubin, Mohammad K. Khan, Gerardo Salerno, Waleed F. Mourad, Weisi Yan & Branislav Jeremic. (2019) Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment. Radiation Oncology 14:1.
Crossref
Crossref
Qianqian Zhao, Gang Chen, Luxi Ye, Shiming Shi, Shisuo Du, Zhaochong Zeng & Jian He. (2019) Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC. Radiation Oncology 14:1.
Crossref
Crossref
Guangyin Wu, Michael J. Baine, Nan Zhao, Sicong Li, Xiaobo Li & Chi Lin. (2019) Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer. BMC Cancer 19:1.
Crossref
Crossref
Clemens Grassberger, Susannah G. Ellsworth, Moses Q. Wilks, Florence K. Keane & Jay S. Loeffler. (2019) Assessing the interactions between radiotherapy and antitumour immunity. Nature Reviews Clinical Oncology 16:12, pages 729-745.
Crossref
Crossref
Yeona Cho, Sangjoon Park, Hwa Kyung Byun, Chang Geol Lee, Jaeho Cho, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sinae Kim, Juyoung Park & Hong In Yoon. (2019) Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 105:5, pages 1065-1073.
Crossref
Crossref
Cynthia Terrones-Campos, Bruno Ledergerber, Ivan Richter Vogelius, Lena Specht, Marie Helleberg & Jens Lundgren. (2019) Lymphocyte Count Kinetics, Factors Associated with the End-of-Radiation-Therapy Lymphocyte Count, and Risk of Infection in Patients with Solid Malignant Tumors Treated with Curative-Intent Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 105:4, pages 812-823.
Crossref
Crossref
Lawrence Kleinberg, Lindsey Sloan, Stuart Grossman & Michael Lim. (2019) Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy. Neurosurgery 85:4, pages 441-453.
Crossref
Crossref
Xi-Lei Zhou, Wei-Guo Zhu, Zhi-Jian Zhu, Wan-Wei Wang, Xue Deng, Wei-Jing Tao, Fu-Zhi Ji & Yu-Suo Tong. (2019) Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy. The Oncologist 24:8, pages e677-e686.
Crossref
Crossref
Hongqi Li, Vivek Verma, Eric D. Brooks, Lei Feng, Tiening Zhang, James W. Welsh, Steven H. Lin, Daniel Gomez, Saumil Gandhi, John V. Heymach & Joe Y. Chang. (2019) Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non–small-cell Lung Cancer. Clinical Lung Cancer 20:4, pages e480-e488.
Crossref
Crossref
Nuradh Joseph, Alan McWilliam, Jason Kennedy, Kate Haslett, Jasmin Mahil, Abhilash Gavarraju, Hitesh Mistry, Marcel Van Herk, Corinne Faivre-Finn & Ananya Choudhury. (2019) Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy. Radiotherapy and Oncology 135, pages 115-119.
Crossref
Crossref
Vidhya Karivedu, Rishi Agarwal, Sulsal Ul Haque, Bicky Thapa, Farhad Fakhrejahani, Pingfu Fu, Gregory M. M. Videtic & Nooshin Hashemi Sadraei. (2019) Lymphopenia as a predictor of survival in chemoradiation-treated stage III non-small-cell lung cancer (NSCLC): a multi-center retrospective analysis. Journal of Radiation Oncology 8:2, pages 163-170.
Crossref
Crossref
Michael D. Schad, Sunil W. Dutta, Donald M. Muller, Krishni Wijesooriya & Timothy N. Showalter. (2019) Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer. Advances in Radiation Oncology 4:2, pages 323-330.
Crossref
Crossref
Dilan A. Patel, Jing Xi, Jingqin Luo, Bilal Hassan, Shana Thomas, Cynthia X. Ma & Jian L. Campian. (2019) Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer. Breast Cancer Research and Treatment 174:2, pages 443-452.
Crossref
Crossref
Yasunori Yoshino, Ayumi Taguchi, Maki Takao, Tomoko Kashiyama, Akiko Furusawa, Masaya Uno, Satoshi Okada, Nao Kino & Toshiharu Yasugi. (2018) Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer. International Journal of Clinical Oncology 24:4, pages 428-436.
Crossref
Crossref
Katrin Rabold, Paul R. Gielen, Esther D. Kers-Rebel, Mihai G. Netea, Jan W.A. Smit, Gosse J. Adema & Romana T. Netea-Maier. (2019) T-Cell Lymphopenia in Patients with Advanced Thyroid Carcinoma Is Associated with Poor Prognosis. The Oncologist 24:3, pages e106-e110.
Crossref
Crossref
T. Karantanos, S. Karanika, B. Seth & G. Gignac. (2018) The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study. Clinical and Translational Oncology 21:2, pages 206-212.
Crossref
Crossref
Stephanie M. Lewkiewicz, Yao-Li Chuang & Tom Chou. (2019) Dynamics of T cell receptor distributions following acute thymic atrophy and resumption. Mathematical Biosciences and Engineering 17:1, pages 28-55.
Crossref
Crossref
Sangjoon Park, Hwa Kyung Byun & Jinsil Seong. (2019) Irradiation-Related Lymphopenia for Bone Metastasis from Hepatocellular Carcinoma. Liver Cancer 8:6, pages 468-479.
Crossref
Crossref
David M. Routman, Aurelie Garant, Scott C. Lester, Courtney N. Day, William S. Harmsen, Cristobal T. Sanheuza, Harry H. Yoon, Michelle A. Neben-Wittich, James A. Martenson, Michael G. Haddock, Christopher L. Hallemeier & Kenneth W. Merrell. (2019) A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer. Advances in Radiation Oncology 4:1, pages 63-69.
Crossref
Crossref
Won Jin Ho, Mark Yarchoan, Alex Hopkins, Ranee Mehra, Stuart Grossman & Hyunseok Kang. (2018) Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Crossref
Yang Liu, Yinping Dong, Li Kong, Fang Shi, Hui Zhu & Jinming Yu. (2018) Abscopal effect of radiotherapy combined with immune checkpoint inhibitors. Journal of Hematology & Oncology 11:1.
Crossref
Crossref
Susannah G. Ellsworth. (2018) Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors. Advances in Radiation Oncology 3:4, pages 512-519.
Crossref
Crossref
Ryoko Suzuki, Xiong Wei, Pamela K. Allen, James W. Welsh, Ritsuko Komaki & Steven H. Lin. (2018) Hematologic variables associated with brain failure in patients with small-cell lung cancer. Radiotherapy and Oncology 128:3, pages 505-512.
Crossref
Crossref
Jessika A. Contreras, Alexander J. Lin, Ashley Weiner, Christina Speirs, Pamela Samson, Daniel Mullen, Jian Campian, Jeffrey Bradley, Michael Roach & Clifford Robinson. (2018) Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer. Radiotherapy and Oncology 128:3, pages 498-504.
Crossref
Crossref
Lourdes Barrera, Edgar Montes-Servín, Juan-Manuel Hernandez-Martinez, Mario Orozco-Morales, Elizabeth Montes-Servín, David Michel-Tello, Renato Augusto Morales-Flores, Diana Flores-Estrada & Oscar Arrieta. (2018) Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer. Cancer Immunology, Immunotherapy 67:9, pages 1393-1406.
Crossref
Crossref
Roy E Strowd, Gregory Russell, Fang-Chi Hsu, Annette F Carter, Michael Chan, Stephen B Tatter, Adrian W Laxton, Martha A Alexander-Miller, Kevin High & Glenn J Lesser. (2018) Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancy. Neuro-Oncology Practice 5:3, pages 176-183.
Crossref
Crossref
Yutaka Shiraishi, Penny Fang, Cai Xu, Juhee Song, Sunil Krishnan, Eugene J. Koay, Reza J. Mehran, Wayne L. Hofstetter, Mariela Blum-Murphy, Jaffer A. Ajani, Ritsuko Komaki, Bruce Minsky, Radhe Mohan, Charles C. Hsu, Brian P. Hobbs & Steven H. Lin. (2018) Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. Radiotherapy and Oncology 128:1, pages 154-160.
Crossref
Crossref
Yao‐Yu Wu, Kai‐Ping Chang, Chien‐Yu Lin, Ping‐Ching Pai, Hung‐Ming Wang, Cheng‐Lung Hsu, Chun‐Ta Liao, Tzu‐Chen Yen, Tuan‐Jen Fang, Shiang‐Fu Huang, Chung‐Jan Kang, Ku‐Hao Fang, Wan‐Ni Lin, Yu‐Chien Wang, Li‐Jen Hsin & Ngan‐Ming Tsang. (2018) Prognostic significance of combined pretreatment lymphocyte counts and body mass index in patients with head and neck cancer treated with radiation therapy. Cancer Medicine 7:7, pages 2808-2815.
Crossref
Crossref
Ryoko Suzuki, Steven H. Lin, Xiong Wei, Pamela K. Allen, James W. Welsh, Lauren A. Byers & Ritsuko Komaki. (2018) Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer. Radiotherapy and Oncology 126:3, pages 499-505.
Crossref
Crossref
Bhanu Prasad Venkatesulu, Supriya Mallick, Steven H. Lin & Sunil Krishnan. (2018) A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. Critical Reviews in Oncology/Hematology 123, pages 42-51.
Crossref
Crossref
Li-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Ming-Yuan Chen, Chong Zhao, Xiang Guo, Chao-Nan Qian, Mu-Sheng Zeng, Jin-Xin Bei, Jing Tan, Shuai Chen, Ming-Huang Hong, Jian-Yong Shao, Ying Sun, Jun Ma & Hai-Qiang Mai. (2018) The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients. Cancer Research and Treatment 50:1, pages 19-29.
Crossref
Crossref
Eric C. Ko & Silvia C. Formenti. (2018) Radiotherapy and checkpoint inhibitors: a winning new combination?. Therapeutic Advances in Medical Oncology 10, pages 175883591876824.
Crossref
Crossref
Seung Yeop Oh, Jaesung Heo, O Kyu Noh, Mison Chun, Oyeon Cho & Young-Taek Oh. (2018) Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance. Technology in Cancer Research & Treatment 17, pages 153303381878006.
Crossref
Crossref
Jian L. Campian, Anna F. Piotrowski, Xiaobu Ye, Frances T. Hakim, Jeremy Rose, Xiao-Yi Yan, Yao Lu, Ronald Gress & Stuart A. Grossman. (2017) Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide. Journal of Neuro-Oncology 135:2, pages 343-351.
Crossref
Crossref
Liliana Vasquez, Esmeralda León, Brady Beltran, Ivan Maza, Monica Oscanoa & Jenny Geronimo. (2017) Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery: Independent Prognostic Factors for Survival in Pediatric Sarcomas. Journal of Pediatric Hematology/Oncology 39:7, pages 538-546.
Crossref
Crossref
Kylie H Kang, Jimmy T Efird, Neelesh Sharma, Michael Yang, Afshin Dowlati, Philip Linden, Mitchell Machtay & Tithi Biswas. (2017) Prognostic potential of neutrophil-to-lymphocyte ratio and lymphocyte nadir in stage III non-small-cell lung cancer. Future Oncology 13:16, pages 1405-1414.
Crossref
Crossref
Awalpreet S. Chadha, Guan Liu, Hsiang-Chun Chen, Prajnan Das, Bruce D. Minsky, Usama Mahmood, Marc E. Delclos, Yelin Suh, Gabriel O. Sawakuchi, Sam Beddar, Matthew H. Katz, Jason B. Fleming, Milind M. Javle, Gauri R. Varadhachary, Robert A. Wolff, Christopher H. Crane, Xuemei Wang, Howard Thames & Sunil Krishnan. (2017) Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?. International Journal of Radiation Oncology*Biology*Physics 97:2, pages 323-332.
Crossref
Crossref
Shereen El Shorbagy, Ola M. Elfarargy, Reham A. Salem, Amina M. Elnaggar, Ola A. Harb, Abeer M. Abdelbary, Hassan R. Ashour & Loay M. Gertallah. (2017) Peripheral and Tissue Lymphocytes as Predictors of Pathological Response in Locally Advanced Rectal Cancer Post Neoadjuvant Chemoradiotherapy. Journal of Cancer Therapy 08:03, pages 250-267.
Crossref
Crossref
Brenda M. Lee, Andrea Rodríguez, Gabriel Mena, Vijaya Gottumukkala, Reza J. Mehran, David C. Rice, Lei Feng, Jun Yu & Juan P. Cata. (2016) Platelet-to-Lymphocyte Ratio and Use of NSAIDs during the Perioperative Period as Prognostic Indicators in Patients with NSCLC Undergoing Surgery. Cancer Control 23:3, pages 284-294.
Crossref
Crossref
Wen ChengXiufang RenChuanbao ZhangJinquan CaiYang LiuSheng HanAnhua Wu. (2016) Bioinformatic profiling identifies an immune-related risk signature for glioblastoma. Neurology 86:24, pages 2226-2234.
Crossref
Crossref
Furong Kou, Zhihao Lu, Jian Li, Xiaotian Zhang, Ming Lu, Jun Zhou, Xicheng Wang, Jifang Gong, Jing Gao, Jie Li, Yan Li & Lin Shen. (2016) Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first‐line chemotherapy. Cancer Medicine 5:5, pages 778-786.
Crossref
Crossref
Joe S. Mendez, Ashwin Govindan, Jacqueline Leong, Feng Gao, Jiayi Huang & Jian L. Campian. (2016) Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma. Journal of Neuro-Oncology 127:2, pages 329-335.
Crossref
Crossref
Oyeon Cho, Young‐Taek Oh, Mison Chun, O‐Kyu Noh, Jae‐Sung Hoe & Hwanik Kim. (2015) Minimum absolute lymphocyte count during radiotherapy as a new prognostic factor for nasopharyngeal cancer. Head & Neck 38:S1.
Crossref
Crossref
Aaron T. Wild, Joseph M. Herman, Avani S. Dholakia, Shalini Moningi, Yao Lu, Lauren M. Rosati, Amy Hacker-Prietz, Ryan K. Assadi, Ali M. Saeed, Timothy M. Pawlik, Elizabeth M. Jaffee, Daniel A. Laheru, Phuoc T. Tran, Matthew J. Weiss, Christopher L. Wolfgang, Eric Ford, Stuart A. Grossman, Xiaobu Ye & Susannah G. Ellsworth. (2016) Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics 94:3, pages 571-579.
Crossref
Crossref
Jaesung Heo, Mison Chun, O Kyu Noh, Young-Taek Oh, Kwang Wook Suh, Jun Eun Park & Oyeon Cho. (2016) Sustaining Blood Lymphocyte Count during Preoperative Chemoradiotherapy as a Predictive Marker for Pathologic Complete Response in Locally Advanced Rectal Cancer. Cancer Research and Treatment 48:1, pages 232-239.
Crossref
Crossref
Kim A. Reiss, Dvone C. Jackson, Anna Piotrowski, Stuart Grossman & Joel N. Blankson. (2016) Immune Control Despite Protracted Lymphopenia After Chemoradiation in an Elite Controller. Open Forum Infectious Diseases 3:1.
Crossref
Crossref
Emily S. Wu, Titilope Oduyebo, Lauren P. Cobb, Diana Cholakian, Xiangrong Kong, Amanda N. Fader, Kimberly L. Levinson, Edward J. TannerIIIIII, Rebecca L. Stone, Anna Piotrowski, Stuart Grossman & Kara Long Roche. (2016) Lymphopenia and its association with survival in patients with locally advanced cervical cancer. Gynecologic Oncology 140:1, pages 76-82.
Crossref
Crossref
Oyeon Cho, Young-Taek Oh, Mison Chun, O Kyu Noh & Hyun-Woo Lee. (2015) Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer. Tumor Biology 37:1, pages 971-978.
Crossref
Crossref
Eric T Wong & Kenneth D Swanson. (2015) Response to: Comment on ‘Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma’. British Journal of Cancer 113:11, pages 1633-1634.
Crossref
Crossref
Susannah Ellsworth & Stuart A Grossman. (2015) Comment on ‘Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma’. British Journal of Cancer 113:11, pages 1632-1633.
Crossref
Crossref
Harminder S. Takhar, Nimit Singhal, Raghu Gowda, Michael Penniment, Parineet Takhar & Michael P. Brown. (2015) Phase I study evaluating the safety and efficacy of oral panobinostat in combination with radiotherapy or chemoradiotherapy in patients with inoperable stage III non-small-cell lung cancer. Anti-Cancer Drugs 26:10, pages 1069-1077.
Crossref
Crossref
Vaishali Kapoor, Arpine Khudanyan, Pilar de la Puente, Jian Campian, Dennis E. Hallahan, Abdel Kareem Azab & Dinesh Thotala. (2015) Stem Cell Transfusion Restores Immune Function in Radiation-Induced Lymphopenic C57BL/6 Mice. Cancer Research 75:17, pages 3442-3445.
Crossref
Crossref
Jian L. Campian, Xiaobu Ye, Douglas E. Gladstone, Prakash Ambady, Thomas R. Nirschl, Ivan Borrello, Marc Golightly, Karen E. King, Matthias Holdhoff, Judith Karp, Charles G. Drake & Stuart A. Grossman. (2015) Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas. Journal of Neuro-Oncology 124:2, pages 307-316.
Crossref
Crossref
Jian L. Campian, Guneet Sarai, Xiaobu Ye, Shanthi Marur & Stuart A. Grossman. (2014) Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer. Head & Neck 36:12, pages 1747-1753.
Crossref
Crossref
Peiwen Kuo, Scott V. Bratman, David B. Shultz, Rie von Eyben, Cato Chan, Ziwei Wang, Carmen Say, Aparna Gupta, Bill W. LooJrJr, Amato J. Giaccia, Albert C. Koong, Maximilian Diehn & Quynh-Thu Le. (2014) Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response. Clinical Cancer Research 20:21, pages 5558-5569.
Crossref
Crossref
D. A. Reardon, G. Freeman, C. Wu, E. A. Chiocca, K. W. Wucherpfennig, P. Y. Wen, E. F. Fritsch, W. T. Curry, J. H. Sampson & G. Dranoff. (2014) Immunotherapy advances for glioblastoma. Neuro-Oncology 16:11, pages 1441-1458.
Crossref
Crossref
Chad Tang, Zhongxing Liao, Daniel Gomez, Lawrence Levy, Yan Zhuang, Rediet A. Gebremichael, David S. Hong, Ritsuko Komaki & James W. Welsh. (2014) Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes. International Journal of Radiation Oncology*Biology*Physics 89:5, pages 1084-1091.
Crossref
Crossref
Yaacov Richard Lawrence & Adam P Dicker. (2014) Radiation therapy and the immune system: learning to live together. Future Oncology 10:5, pages 777-780.
Crossref
Crossref
Jing Zeng, Timothy J. Harris, Michael Lim, Charles G. Drake & Phuoc T. Tran. (2013) Immune Modulation and Stereotactic Radiation: Improving Local and Abscopal Responses. BioMed Research International 2013, pages 1-8.
Crossref
Crossref